Three researchers at the ARVO 2017 Annual Meeting will share their latest results, including: Who will get AMD? Teaching algorithms to predict who’s at risk; Restoring vision: New hope for retinal cell replacement, and Prenatal marijuana use: Potential long-term effects on babies’ eyes.
The Association for Research in Vision and Ophthalmology (ARVO) urges Congressional leaders to reject the U.S. administration’s recent FY18 budget proposal, which seeks to drastically cut National Institute of Health funding by nearly $6 billion, or 20%. These cuts would be devastating to the current and future efforts of the eye and vision research community and to patients who desperately count on the efforts of researchers and clinicians to save their sight.
e Association for Research in Vision and Ophthalmology (ARVO) has joined with other scientific societies in partnering with the March for Science, a mass outpouring of non-partisan support for science and the scientific community.
Vision scientists may have discovered how to reduce pedestrian collisions in crowded and chaotic open space environments like bus terminals, shopping malls and city plazas involving individuals with partial blindness. Researchers have determined from which direction collisions with partially blind pedestrians are most likely to originate. This understanding will guide the development of new glasses that expand the sight of a person with limited peripheral vision.
Scientists have found that with minimal training, members of the general public may be able to match the accuracy of experts in interpreting medical images of the eye. The work, published in Translational Vision Science & Technology (TVST), introduces a world where individuals without medical training could contribute to decisions made in the clinic.
To celebrate its revolutionary impact on eye care around the world, the Associatio n for Research in Vision and Ophthalmology (ARVO) has independently produced a series of short videos, educational tools and advocacy resources on the discovery and development of optical coherence tomography (OCT).
To provide a better view of difficult to see tissue, Japanese researchers have miniaturized an imaging probe to fit inside a needle that can be inserted into the eye during eye surgery. The probe was used without complications in three human patients, as described in an article published in Investigative Ophthalmology & Visual Science (IOVS).
The journal Investigative Ophthalmology & Visual Science (IOVS) is commemorating the 25th anniversary of the development of optical coherence tomography (OCT) with the release of a special issue of more than 70 papers from authors on five continents.
Scientists may have overcome a major roadblock in the development of Alzheimer’s therapies by creating a new technology to observe ― in the back of the eye ― progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science ( IOVS).
A recent study shows that infants and toddlers take longer to notice new visual stimuli and are less accurate in their gaze than adults, but slowly improve as they age. The findings reinforce the importance of raising young children in stimulating environments, and set an important baseline as detection of developmental disorders increasingly rely on tracking eye movements. The paper, “Development and learning of saccadic eye movements in 7-42 month-old children” was published in the Journal of Vision.
Early structural changes in the back of the eye — now visible with a newly developed eye scan — may indicate the onset of Alzheimer’s disease. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
Building on existing evidence, vision researchers have found that limiting exposure to blue light after sunset increases the quality and length of sleep. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
Pterostilbene (PS), a component of blueberries, have been found to protect against dry eye disease according to a new study. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
Researchers have safely transplanted stem cells derived from a patient’s skin to the back of the eye in an effort to restore vision. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
Scientists have successfully implanted a prosthesis that restores some central vision in patients with only limited peripheral vision remaining to them – the first time artificial and natural vision has ever been integrated in humans. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
According to new research, injection of 3-hydroxybutyrate (3HB) offers similar protection as a low calorie diet against nerve degeneration in rats with glaucoma. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Seattle, Wash.
The Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) is the largest gathering of eye and vision researchers in the world, with over 11,000 attendees from more than 75 countries. Two free events will feature speakers highlighting recent successes — and emerging threats — facing ophthalmic clinicians and researchers around the world.
This ARVO Meeting showcases cutting-edge eye and vision science and an early glimpse into the latest advances in potential treatments for eye disease and blindness — often years ahead of their introduction to the clinic.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right